This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: University of California, University of Delaware. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2019
Title: April M Kloxin: Innovator in Hydrogel Technology
Introduction
April M Kloxin is a prominent inventor based in Landenberg, Pennsylvania. She has made significant contributions to the field of materials science, particularly in the development of innovative hydrogel technologies. Her work focuses on creating responsive materials that can be utilized for various applications, including drug delivery systems.
Latest Patents
Kloxin holds a patent for "Multimode degradable hydrogels for controlled release of cargo substances." This patent describes a responsive hydrogel-based material that serves as a carrier system for the in situ delivery of various cargo substances, including bioactive moieties. The hydrogel structure incorporates photodegradable and thioether moieties within its three-dimensional network. This design allows for finely tuned local release of cargo substances based on the in vivo tissue environment and externally applied stimuli, such as light.
Career Highlights
Throughout her career, Kloxin has worked at esteemed institutions, including the University of Delaware and the University of California. Her research has garnered attention for its potential applications in biomedical fields, particularly in drug delivery and tissue engineering.
Collaborations
Kloxin has collaborated with notable colleagues, including Kristi Kiick and Prathamesh M Kharkar. These partnerships have further advanced her research and contributed to the development of innovative hydrogel technologies.
Conclusion
April M Kloxin is a trailblazer in the field of hydrogel technology, with her patent and research paving the way for future advancements in controlled release systems. Her contributions continue to impact the scientific community and hold promise for various applications in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile